125 related articles for article (PubMed ID: 11693822)
1. Surgical treatment of medullary carcinoma of the thyroid.
Favia G; Lumachi F
Tumori; 2001; 87(4):S49-51. PubMed ID: 11693822
[No Abstract] [Full Text] [Related]
2. Total thyroidectomy for hereditary medullary thyroid carcinoma 12 years after correction of Hirschsprung's disease.
Sasaki Y; Shimotake T; Go S; Iwai N
Eur J Surg; 2001 Jun; 167(6):467-9. PubMed ID: 11471675
[No Abstract] [Full Text] [Related]
3. A novel germline point mutation, c.2304 G-->T, in codon 768 of the RET proto-oncogene in a patient with medullary thyroid carcinoma.
Antiñolo G; Marcos I; Fernández RM; Romero M; Borrego S
Am J Med Genet; 2002 Jun; 110(1):85-7. PubMed ID: 12116277
[No Abstract] [Full Text] [Related]
4. A new identified germline mutation of the RET proto-oncogene responsible for familial medullary thyroid carcinoma in co-existence with a hyperfunctioning autonomous nodule.
Maschek W; Pichler R; Rieger R; Weinhäusel A; Berg J
Clin Endocrinol (Oxf); 2002 Jun; 56(6):823. PubMed ID: 12072055
[No Abstract] [Full Text] [Related]
5. Familial medullary thyroid carcinoma and prominent corneal nerves associated with the germline V804M and V778I mutations on the same allele of RET.
Kasprzak L; Nolet S; Gaboury L; Pavia C; Villabona C; Rivera-Fillat F; Oriola J; Foulkes WD
J Med Genet; 2001 Nov; 38(11):784-7. PubMed ID: 11732489
[No Abstract] [Full Text] [Related]
6. Editorial review of "Malignant progression from C-cell hyperplasia to medullary thyroid carcinoma in 167 RET germline mutations".
Wilhelm S; Prinz RA
Surgery; 2004 Apr; 135(4):447-8. PubMed ID: 15041969
[No Abstract] [Full Text] [Related]
7. [C cell hyperplasia and medullary microcarcinomas of the thyroid].
Guyetant S; Saint-Andre JP
Ann Pathol; 2000; 20 Suppl():S39-44. PubMed ID: 11261296
[No Abstract] [Full Text] [Related]
8. Familial medullary thyroid carcinoma with noncysteine ret mutations: phenotype-genotype relationship in a large series of patients.
Niccoli-Sire P; Murat A; Rohmer V; Franc S; Chabrier G; Baldet L; Maes B; Savagner F; Giraud S; Bezieau S; Kottler ML; Morange S; Conte-Devolx B;
J Clin Endocrinol Metab; 2001 Aug; 86(8):3746-53. PubMed ID: 11502806
[TBL] [Abstract][Full Text] [Related]
9. Unilateral renal agenesis in a family with medullary thyroid carcinoma.
Loré F; Di Cairano G; Talidis F
N Engl J Med; 2000 Apr; 342(16):1218-9. PubMed ID: 10777380
[No Abstract] [Full Text] [Related]
10. Simultaneous occurrence of a medullary and a papillary thyroid carcinoma in the same patient.
Tseleni-Balafouta S; Grigorakis SI; Alevizaki M; Karaiskos C; Davaris P; Koutras DA
Gen Diagn Pathol; 1997 Jun; 142(5-6):371-4. PubMed ID: 9228264
[TBL] [Abstract][Full Text] [Related]
11. RET activation in medullary carcinomas.
Pierotti MA; Arighi E; Degl'innocenti D; Borrello MG
Cancer Treat Res; 2004; 122():389-415. PubMed ID: 16209058
[No Abstract] [Full Text] [Related]
12. A case of metastatic medullary thyroid carcinoma: early identification before surgery of an RET proto-oncogene somatic mutation in fine-needle aspirate specimens.
Russo D; Arturi F; Chiefari E; Meringolo D; Bianchi D; Bellanova B; Filetti S
J Clin Endocrinol Metab; 1997 Oct; 82(10):3378-82. PubMed ID: 9329372
[TBL] [Abstract][Full Text] [Related]
13. A nationwide clinical survey of patients with multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma in Japan.
Iihara M; Yamashita T; Okamoto T; Kanbe M; Yamazaki K; Egawa S; Yamaguchi K; Obara T
Jpn J Clin Oncol; 1997 Jun; 27(3):128-34. PubMed ID: 9255265
[TBL] [Abstract][Full Text] [Related]
14. Identification of a novel somatic mutation in the RET proto-oncogene in a patient with sporadic medullary thyroid carcinoma.
Matias-Guiu X; Lagarda E; Calaf M; Azpiroz A; De Leiva A; Prat J; Baiget M
Hum Mutat; 1997; 9(5):476. PubMed ID: 9143934
[No Abstract] [Full Text] [Related]
15. Does a somatic deletion in RET clarify the sporadic nature of medullary thyroid carcinoma?
Gimm O; Marsh DJ
J Endocrinol Invest; 2003 Apr; 26(4):381-3. PubMed ID: 12841548
[No Abstract] [Full Text] [Related]
16. Current management of medullary thyroid cancer.
Sippel RS; Kunnimalaiyaan M; Chen H
Oncologist; 2008 May; 13(5):539-47. PubMed ID: 18515739
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneous mutation of the RET proto-oncogene in subpopulations of medullary thyroid carcinoma.
Eng C; Mulligan LM; Healey CS; Houghton C; Frilling A; Raue F; Thomas GA; Ponder BA
Cancer Res; 1996 May; 56(9):2167-70. PubMed ID: 8616867
[TBL] [Abstract][Full Text] [Related]
18. [Endocrine surgery. Series 6: Alteration of RET proto-oncogene and clinical implication in medullary thyroid carcinoma. Genetic screening of family members at risk for inherited medullary thyroid carcinoma].
Kitamura Y; Shimizu K; Tanaka S
Nihon Ika Daigaku Zasshi; 1996 Jun; 63(3):228-32. PubMed ID: 8707923
[No Abstract] [Full Text] [Related]
19. A new germline mutation, R600Q, within the coding region of RET proto-oncogene: a rare polymorphism or a MEN 2 causing mutation?
Sáez ME; Ruiz A; Cebrián A; Morales F; Robledo M; Antiñolo G; Borrego S
Hum Mutat; 2000 Jan; 15(1):122. PubMed ID: 10612852
[No Abstract] [Full Text] [Related]
20. Treatment of minute medullary thyroid carcinoma in multiple endocrine neoplasia 2A families first diagnosed by DNA analysis of RET proto-oncogene mutations: a case report.
Yamashita T; Lihara M; Okamoto J; Kanbe M; Ito Y; Kawakami M; Egawa S; Yamaguchi K; Obara T
Jpn J Clin Oncol; 1997 Feb; 27(1):42-5. PubMed ID: 9070340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
